Cargando…
Genomic and neoantigen evolution from primary tumor to first metastases in head and neck squamous cell carcinoma
Head and neck cell squamous-cell carcinomas (HNSCC) are a group of common cancers typically associated with tobacco use and human papilloma virus infection. Up to half of all cases will suffer a recurrence after primary treatment. As such, new therapies are needed, including therapies which promote...
Autores principales: | Schutt, Charles R., Sun, Hua, Pradhan, Jaya Sarin, Saenger, Yvonne, Ley, Jessica, Adkins, Douglas, Ingham, Matthew, Ding, Li, Van Tine, Brian A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984826/ https://www.ncbi.nlm.nih.gov/pubmed/33796222 http://dx.doi.org/10.18632/oncotarget.27907 |
Ejemplares similares
-
Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma
por: Ren, Lili, et al.
Publicado: (2019) -
Neoantigen evolution in head and neck cancer progression: where do we go from here?
por: Rosenberg, Ari Joseph, et al.
Publicado: (2021) -
Generation of neoantigen-specific T cells for adoptive cell transfer for treating head and neck squamous cell carcinoma
por: Wei, Teng, et al.
Publicado: (2021) -
A prospective trial comparing FDG-PET/CT and CT to assess tumor response to cetuximab in patients with incurable squamous cell carcinoma of the head and neck
por: Adkins, Douglas, et al.
Publicado: (2014) -
Metastases of head and neck squamous cell carcinoma to soft tissue of fingertips
por: Shetty, Nishitha, et al.
Publicado: (2016)